The recent Webinar Wednesday presentation “Maximizing Investment in Your IoMT Devices” was presented by Asimily Senior Director of Product Management Jeremy Linden and Renovo Vice President of Information Technology Greg Scott. It was sponsored by Asimily and eligible for 1 credit from the ACI.
Health care delivery organizations (HDOs) make significant investments in their Internet of Medical Things (IoMT) devices, but how do they know if they’re getting their money’s worth? Linden and Scott shared how individuals can learn to build efficiency into the procurement process. One key is to purchase devices without major cybersecurity liabilities and configure them securely. Once devices are deployed, discover how to use utilization monitoring to track where, when and how they are being used in the field, allowing HTM professionals to plan capacity accurately and avoid buying more devices than needed.
Linden and Scott also fielded questions from attendees to provide additional insights.
One question asked, “We have noticed that we often have MDS2 forms that don’t seem to exactly match the devices in our environment. What is the best way to handle this issue?”
“Yeah, that’s a good question, and that’s actually something that we noticed, too, right? It’s a difficult technical challenge, and it’s actually a technical challenge that we’ve worked on ourselves,” Linden said. “In many cases, what the manufacturer puts in the MDS2 is often vague, or it’s not clear, which versions it actually applies to. And, it’s often not clear what version you even have, right, depending on the device and the device type. So, that’s work that has been done in software platforms like ours.”
“You actually can go in and you can actually see the differences between different versions,” he added.
He went on to say that there are different ways to handle it and some are easier than others.
The presenters answered more questions and the Q&A session is included in the on-demand version of the webinar available at WebinarWednesday.live.
Attendees provided feedback in a post-webinar survey that included the question, “What do you like best about the Webinar Wednesday webinar series?”
“I am a new biomed tech, so this information is very informative for me, especially today’s topic,” Biomedical Engineering Technician A. McCray said.
“Gathering information and seeing things from other people’s perspective,” said J. Vrabel, CBET.
“Very helpful to clinical engineering teams across the country to learn, grow and network,” Clinical Engineering Manager W. Doiel said.
For more information, visit WebinarWednesday.live.
